{"entity":{"type":"insider","cik":"0001799081","url":"/insider/0001799081","json_url":"/insider/0001799081.json","name":"Taylor Stacy L","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":41,"n_filings":25,"first":"2020-01-10","last":"2024-08-23","span_basis":"filed_date"},"name_variants":[{"name":"Taylor Stacy L","source":"filing","n_filings":25,"first_seen":"2020-01-10","last_seen":"2024-08-23"}],"transactions":[{"id":2598185,"accession":"0001062993-24-015606","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-24-015606","line_url":"/filing/0001062993-24-015606#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26922.0,"shares_display":"26,922","price_per_share":4.4974,"price_display":"4.50","price_state":"stated","total_value":121079.0028,"total_display":"121,079.00","total_whole":"121,079","shares_owned_after":139365.0,"shares_owned_after_display":"139,365","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-23","scope":"insider"},{"id":3115389,"accession":"0001062993-24-005766","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-24-005766","line_url":"/filing/0001062993-24-005766","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13381.0,"shares_display":"13,381","price_per_share":3.4349390927434422,"price_display":"3.43","price_state":"stated","total_value":45962.92,"total_display":"45,962.92","total_whole":"45,963","shares_owned_after":172896.0,"shares_owned_after_display":"172,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-05","filed_date":"2024-03-06","scope":"insider","n_lines":2},{"id":8218276,"accession":"0001062993-23-006328","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-23-006328","line_url":"/filing/0001062993-23-006328#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13387.0,"shares_display":"13,387","price_per_share":8.6,"price_display":"8.60","price_state":"stated","total_value":115128.2,"total_display":"115,128.20","total_whole":"115,128","shares_owned_after":139678.0,"shares_owned_after_display":"139,678","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-07","filed_date":"2023-03-08","scope":"insider"},{"id":8218272,"accession":"0001062993-23-006328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-006328","line_url":"/filing/0001062993-23-006328#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5491.0,"shares_display":"5,491","price_per_share":8.57,"price_display":"8.57","price_state":"stated","total_value":47057.87,"total_display":"47,057.87","total_whole":"47,058","shares_owned_after":153065.0,"shares_owned_after_display":"153,065","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-06","filed_date":"2023-03-08","scope":"insider"},{"id":6097473,"accession":"0001209191-22-018095","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018095","line_url":"/filing/0001209191-22-018095#line-1","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2387.0,"shares_display":"2,387","price_per_share":11.44,"price_display":"11.44","price_state":"stated","total_value":27307.28,"total_display":"27,307.28","total_whole":"27,307","shares_owned_after":72859.0,"shares_owned_after_display":"72,859","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-08","filed_date":"2022-03-10","scope":"insider"},{"id":6607516,"accession":"0001209191-22-017397","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-017397","line_url":"/filing/0001209191-22-017397#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1569.0,"shares_display":"1,569","price_per_share":12.01,"price_display":"12.01","price_state":"stated","total_value":18843.69,"total_display":"18,843.69","total_whole":"18,844","shares_owned_after":75246.0,"shares_owned_after_display":"75,246","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-07","filed_date":"2022-03-08","scope":"insider"},{"id":5385463,"accession":"0001209191-21-071194","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-071194","line_url":"/filing/0001209191-21-071194#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15338.0,"shares_display":"15,338","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":460140.0,"total_display":"460,140.00","total_whole":"460,140","shares_owned_after":15036.0,"shares_owned_after_display":"15,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-23","scope":"insider"},{"id":4104067,"accession":"0001209191-21-055367","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-055367","line_url":"/filing/0001209191-21-055367#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":495.0,"shares_display":"495","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":19800.0,"total_display":"19,800.00","total_whole":"19,800","shares_owned_after":15036.0,"shares_owned_after_display":"15,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-09","scope":"insider"},{"id":5200529,"accession":"0001209191-21-044630","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-044630","line_url":"/filing/0001209191-21-044630","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4167.0,"shares_display":"4,167","price_per_share":41.42393808495321,"price_display":"41.42","price_state":"stated","total_value":172613.55,"total_display":"172,613.55","total_whole":"172,614","shares_owned_after":15431.0,"shares_owned_after_display":"15,431","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-30","filed_date":"2021-07-01","scope":"insider","n_lines":2},{"id":4094093,"accession":"0001209191-21-042291","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-042291","line_url":"/filing/0001209191-21-042291#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":166640.0,"total_display":"166,640.00","total_whole":"166,640","shares_owned_after":15036.0,"shares_owned_after_display":"15,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-17","filed_date":"2021-06-21","scope":"insider"},{"id":4332034,"accession":"0001209191-21-029626","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-029626","line_url":"/filing/0001209191-21-029626#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4166.0,"shares_display":"4,166","price_per_share":41.93,"price_display":"41.93","price_state":"stated","total_value":174680.38,"total_display":"174,680.38","total_whole":"174,680","shares_owned_after":15036.0,"shares_owned_after_display":"15,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-30","filed_date":"2021-05-03","scope":"insider"},{"id":5042391,"accession":"0001209191-21-024893","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-024893","line_url":"/filing/0001209191-21-024893#line-4","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4167.0,"shares_display":"4,167","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":166680.0,"total_display":"166,680.00","total_whole":"166,680","shares_owned_after":15036.0,"shares_owned_after_display":"15,036","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-31","filed_date":"2021-04-02","scope":"insider"},{"id":4717385,"accession":"0001209191-21-015471","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-015471","line_url":"/filing/0001209191-21-015471","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2812.0,"shares_display":"2,812","price_per_share":55.525721906116644,"price_display":"55.53","price_state":"stated","total_value":156138.33,"total_display":"156,138.33","total_whole":"156,138","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-26","filed_date":"2021-03-01","scope":"insider","n_lines":3},{"id":4983156,"accession":"0001209191-21-011548","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-011548","line_url":"/filing/0001209191-21-011548","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16250.0,"shares_display":"16,250","price_per_share":64.63548676923077,"price_display":"64.64","price_state":"stated","total_value":1050326.66,"total_display":"1,050,326.66","total_whole":"1,050,327","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-16","filed_date":"2021-02-17","scope":"insider","n_lines":3},{"id":5034840,"accession":"0001209191-21-006578","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-21-006578","line_url":"/filing/0001209191-21-006578","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2813.0,"shares_display":"2,813","price_per_share":56.508649129043725,"price_display":"56.51","price_state":"stated","total_value":158958.83,"total_display":"158,958.83","total_whole":"158,959","shares_owned_after":3018.0,"shares_owned_after_display":"3,018","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-29","filed_date":"2021-02-01","scope":"insider","n_lines":3},{"id":2384015,"accession":"0001209191-20-065774","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-065774","line_url":"/filing/0001209191-20-065774","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6530.0,"shares_display":"6,530","price_per_share":57.855624808575804,"price_display":"57.86","price_state":"stated","total_value":377797.23,"total_display":"377,797.23","total_whole":"377,797","shares_owned_after":3301.0,"shares_owned_after_display":"3,301","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-12-31","filed_date":"2020-12-31","scope":"insider","n_lines":3},{"id":2146387,"accession":"0001209191-20-060395","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-060395","line_url":"/filing/0001209191-20-060395","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":46.30504861111111,"price_display":"46.31","price_state":"stated","total_value":133358.54,"total_display":"133,358.54","total_whole":"133,359","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-23","filed_date":"2020-11-24","scope":"insider","n_lines":2},{"id":3047231,"accession":"0001209191-20-056137","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-056137","line_url":"/filing/0001209191-20-056137","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":49.77760416666667,"price_display":"49.78","price_state":"stated","total_value":143359.5,"total_display":"143,359.50","total_whole":"143,360","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-26","filed_date":"2020-10-28","scope":"insider","n_lines":2},{"id":2083723,"accession":"0001209191-20-052268","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-052268","line_url":"/filing/0001209191-20-052268","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":47.77625,"price_display":"47.78","price_state":"stated","total_value":137595.6,"total_display":"137,595.60","total_whole":"137,596","shares_owned_after":1896.0,"shares_owned_after_display":"1,896","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-09-24","filed_date":"2020-09-28","scope":"insider","n_lines":2},{"id":2443519,"accession":"0001209191-20-048165","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-048165","line_url":"/filing/0001209191-20-048165","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":42.58173611111111,"price_display":"42.58","price_state":"stated","total_value":122635.4,"total_display":"122,635.40","total_whole":"122,635","shares_owned_after":1520.0,"shares_owned_after_display":"1,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-24","filed_date":"2020-08-24","scope":"insider","n_lines":3},{"id":2111450,"accession":"0001209191-20-043678","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-043678","line_url":"/filing/0001209191-20-043678#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":36.03,"price_display":"36.03","price_state":"stated","total_value":103766.4,"total_display":"103,766.40","total_whole":"103,766","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-07-24","filed_date":"2020-07-24","scope":"insider"},{"id":3198596,"accession":"0001209191-20-039022","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-039022","line_url":"/filing/0001209191-20-039022#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":46.68,"price_display":"46.68","price_state":"stated","total_value":134438.4,"total_display":"134,438.40","total_whole":"134,438","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-24","filed_date":"2020-06-25","scope":"insider"},{"id":2544226,"accession":"0001209191-20-032804","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-032804","line_url":"/filing/0001209191-20-032804#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2880.0,"shares_display":"2,880","price_per_share":42.0,"price_display":"42.00","price_state":"stated","total_value":120960.0,"total_display":"120,960.00","total_whole":"120,960","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-05-26","filed_date":"2020-05-28","scope":"insider"},{"id":3256547,"accession":"0001209191-20-026231","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-026231","line_url":"/filing/0001209191-20-026231#line-3","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19580.0,"shares_display":"19,580","price_per_share":30.22,"price_display":"30.22","price_state":"stated","total_value":591707.6,"total_display":"591,707.60","total_whole":"591,708","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-27","filed_date":"2020-04-29","scope":"insider"},{"id":9271075,"accession":"0001209191-20-009865","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-009865","line_url":"/filing/0001209191-20-009865#line-1","is_derivative":false,"issuer_cik":"0001799081","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001799081","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":19860.0,"total_display":"19,860.00","total_whole":"19,860","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-02-18","scope":"insider"},{"id":2576683,"accession":"0001209191-20-003083","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-003083","line_url":"/filing/0001209191-20-003083#line-2","is_derivative":false,"issuer_cik":"0001478320","issuer_name":"Adaptive Biotechnologies Corp","issuer_ticker":"ADPT","issuer_name_source":null,"issuer_url":"/issuer/0001478320","owner_cik":"0001799081","owner_name":"Taylor Stacy L","owner_display_name":"Taylor Stacy L","owner_url":"/insider/0001799081","role":"Officer (SVP and General Counsel)","role_mark":"O","role_mark_label":"Officer (SVP and General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP and General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":662.0,"shares_display":"662","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":19860.0,"total_display":"19,860.00","total_whole":"19,860","shares_owned_after":1300.0,"shares_owned_after_display":"1,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-08","filed_date":"2020-01-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":41,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":41,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":41},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001478320","name":"Adaptive Biotechnologies Corp","url":"/issuer/0001478320","role":"Officer (SVP and General Counsel)","n_filings":25,"first_seen":"2020-01-10","last_seen":"2024-08-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001799081","retrieved_at":"2026-08-25T14:06:54+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}